Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Cyclin B2 Antikörper

CCNB2 Reaktivität: Xenopus laevis ELISA, IHC, Coat Wirt: Maus Monoclonal X29-2 unconjugated
Produktnummer ABIN6936587
  • Target Alle Cyclin B2 (CCNB2) Antikörper anzeigen
    Cyclin B2 (CCNB2)
    Reaktivität
    • 86
    • 31
    • 14
    • 4
    • 4
    • 4
    • 4
    • 2
    • 2
    • 2
    • 2
    • 2
    Xenopus laevis
    Wirt
    • 95
    • 4
    • 3
    Maus
    Klonalität
    • 89
    • 13
    Monoklonal
    Konjugat
    • 42
    • 10
    • 10
    • 9
    • 7
    • 7
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser Cyclin B2 Antikörper ist unkonjugiert
    Applikation
    • 55
    • 49
    • 41
    • 14
    • 13
    • 8
    • 5
    • 4
    • 4
    • 3
    • 3
    • 1
    • 1
    • 1
    ELISA, Immunohistochemistry (IHC), Coating (Coat)
    Spezifität
    In eukaryotic cells, mitosis is initiated following the activation of a protein kinase known variously as maturation-promoting factor, M phase specific histone kinase or M-phase kinase. This protein kinase is composed of a catalytic subunit (Cdc2), a regulatory subunit (cyclin B) and a low molecular weight subunit (p13-Suc1). The Cdc/cyclin enzyme is subject to multiple levels of control, of which the regulation of the catalytic subunit by tyrosine phosphorylation is the best understood. Tyrosine phosphorylation inhibits the Cdc2/ cyclin B enzyme, and tyrosine dephosphorylation, occurring at the onset of mitosis, directly activates the pre-MPF complex. Evidence has established that B type cyclins not only act on M phase regulatory subunits of the Cdc2 protein kinase, but also activate the Cdc25A and Cdc25B endogenous tyrosine phosphatase, of which Cdc2 is the physiological substrate. The two B type cyclins, cyclin B1 and cyclin B2, have been shown to have distinct tissue distributions.
    Kreuzreaktivität (Details)
    Mouse. Rat. Human. Xenopus laevis.
    Aufreinigung
    1.0mg/ml of Ab purified from Bioreactor by Protein A/G.
    Immunogen
    Recombinant full-length Xenopus laevis Cyclin B2 protein
    Klon
    X29-2
    Isotyp
    IgG1 kappa
    Top Product
    Discover our top product CCNB2 Primärantikörper
  • Applikationshinweise

    Known_Application: ELISA (For coating, order antibody without BSA), Optimal dilution for a specific application should be determined.

    Positive_Control: HeLa cells. Human cervical tissue (IHC).

    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Konzentration
    1.0 mg/mL
    Buffer
    Prepared in 10 mM PBS, WITHOUT BSA and Azide.
    Konservierungsmittel
    Azide free
    Lagerung
    -20 °C,-80 °C
    Informationen zur Lagerung
    Antibody without azide store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous.
    Haltbarkeit
    24 months
  • Target
    Cyclin B2 (CCNB2)
    Andere Bezeichnung
    CCNB2 (CCNB2 Produkte)
    Synonyme
    HsT17299 antikoerper, CycB2 antikoerper, sb:cb303 antikoerper, cycB2 antikoerper, LOC100136691 antikoerper, C-B2 antikoerper, cyclinb2 antikoerper, hst17299 antikoerper, LOC100282653 antikoerper, cyclin B2 antikoerper, cyclin B2 S homeolog antikoerper, CCNB2 antikoerper, Ccnb2 antikoerper, ccnb2 antikoerper, LOC100136691 antikoerper, LOC100282653 antikoerper, ccnb2.S antikoerper
    Hintergrund
    Ccnb2, CycB2, Cyclin B2, G2 mitotic specific cyclin B2, HsT17299, MGC108931, MGC140694,Cyclin B2
    Cellular localisation: Cytoplasm.
    Molekulargewicht
    51kDa
    Gen-ID
    9133, 194698
    UniProt
    O95067
    Pathways
    Zellzyklus, M Phase
Sie sind hier:
Kundenservice